Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Shell Companies

Financial Services
$10.90 +0.00%

+$0.00 today

Market cap
$264.62M
Beta
0.00
P/E (TTM)
36.7
EPS (TTM)
$0.29
52W Low $10.17High $10.63

Volume 0.00M

Average 0.11M

DMAA EPS (Basic)

Net income attributable to common shareholders divided by the weighted average basic shares outstanding.

Drugs Made In America Acquisition Corp. Ordinary SharesNASDAQ: DMAA

EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026

EPS (Basic) declines year over year

Q1 FY2026 EPS (Basic) of $0.06 fell 100.0% year over year, in line with the -99.8% change in trailing-twelve-month EPS (Basic). Sequentially, it rose 852.4% from the prior quarter.

What to watch

Whether quarterly growth recovers from -100.0% toward the trailing-twelve-month pace of -99.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0.06+852.4% QoQ
Last fiscal yearDec 2025
$0.19+439.3% YoY
LTMMar 2026
$0.2-99.8% YoY
EPS (Basic) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year+439.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

EPS (Basic) history

USD · from the income statement

Latest · FY2025
0.19 USD
Year-over-year change
+439.3%

EPS (Basic) vs competitors

How DMAA compares with its peers on the latest reported figures

  • DMAA's LTM Mar 2026 EPS (Basic) of $0.2 is the 8th highest of the 10 companies compared; the peer median is $0.29.
  • Its year-over-year change of -99.8% is the lowest of 5, against a peer median of +130.5%.
DMAA Competitors Peer median
EPS (Basic) for DMAA and competitors
Company Period LTM YoY 3-year CAGR
TACOBerto Acquisition Corp.LTM Mar 2026$0.35 ——
TACHTitan Acquisition Corp.LTM Mar 2026$0.34 +928.3%—
ALFCenturion Acquisition Corp.LTM Mar 2026$0.32 -31.4%—
OYSEOyster Enterprises II Acquisition CorpLTM Mar 2026$0.3 ——
SIMASIM Acquisition Corp. ILTM Mar 2026$0.29 +24.2%—
MLACMountain Lake Acquisition Corp.LTM Mar 2026$0.26 +236.7%-13.7%
RTACRenatus Tactical Acquisition Corp I Class A Ordinary SharesLTM Mar 2026$0.25 ——
DMAADrugs Made In America Acquisition Corp. Ordinary SharesLTM Mar 2026$0.2 -99.8%—
TACOUBerto Acquisition Corp. UnitLTM Mar 2026$0.19 ——
LOKVLive Oak Acquisition Corp. V Class A Ordinary SharesLTM Mar 2026-$0.34 ——
Peer median (excluding DMAA) $0.29+130.5%-13.7%

Competitors are the stored peer set for DMAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD

Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Intrinsic Alpha fair value

Locked

Current Price

$10.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.